Seres Therapeutics
MCRB
MCRB
70 hedge funds and large institutions have $143M invested in Seres Therapeutics in 2018 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 21 increasing their positions, 27 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
41% less capital invested
Capital invested by funds: $243M → $143M (-$100M)
97% less call options, than puts
Call options by funds: $4K | Put options by funds: $124K
Holders
70
Holding in Top 10
1
Calls
$4K
Puts
$124K
Top Buyers
| 1 | +$356K | |
| 2 | +$218K | |
| 3 | +$145K | |
| 4 |
Russell Investments Group
London,
United Kingdom
|
+$101K |
| 5 |
Two Sigma Investments
New York
|
+$82K |
Top Sellers
| 1 | -$1.67M | |
| 2 | -$808K | |
| 3 | -$154K | |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$147K |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$140K |